SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000899140-22-000481
Filing Date
2022-04-27
Accepted
2022-04-27 14:39:18
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A INFORMATION k042722a.htm DFAN14A 15118
2 PRESS RELEASE, DATED APRIL 27, 2022 k042722b.htm EX-99.1 42207
3 TRANSCRIPT OF VIDEO POSTED TO SAVEATHIRA.COM ON APRIL 27, 2022. k042722c.htm EX-99.2 21634
  Complete submission text file 0000899140-22-000481.txt   80175
Mailing Address
Business Address
KAYNE RICHARD A (Filed by) CIK: 0000884413 (see all company filings)

Type: DFAN14A

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Subject) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-39503 | Film No.: 22858901
SIC: 2836 Biological Products, (No Diagnostic Substances)